Found: 3
Select item for more details and to access through your institution.
Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial.
- Published in:
- Diabetologia, 2020, v. 63, n. 3, p. 473, doi. 10.1007/s00125-019-05065-8
- By:
- Publication type:
- Article
Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 303, doi. 10.1111/dom.13896
- By:
- Publication type:
- Article
Familywise error for multiple time‐to‐event endpoints in a group sequential design.
- Published in:
- Statistics in Medicine, 2024, v. 43, n. 18, p. 3417, doi. 10.1002/sim.10132
- By:
- Publication type:
- Article